Oasis urges Kusuri No Aoki shareholders to oppose Hironori Aoki reelection in August 2026

The fund manager, which says it beneficially owns about 14.1% of the drugstore operator, cited governance concerns including discounted stock options, board changes and a market transfer.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.